Table 1.

Tumor volume doubling

Days
Control12.1 ± 3.1
Gemcitabine11.6 ± 3.1
Cetuximab12.8 ± 3.1
Erlotinib15.4 ± 3.3
IR16.7 ± 3.1
Gem+IR19.2 ± 3.3
Cet+Gem20.1 ± 3.1
Erl+Gem23.8 ± 3.3*
Cet+IR22.5 ± 3.3*
Erl+IR18.4 ± 3.1
Cet+Gem+IR30.1 ± 3.3*§
Erl+Gem+IR27.5 ± 3.3*
  • * P < 0.05 versus Control.

  • Gemcitabine.

  • Cetuximab.

  • § Gem+IR.

  • Cet+Gem.